DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Injection Snoreplasty: Comparison Between Ethanol and Ethanolamine Oleate

Information source: University of Sao Paulo
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Snoring; Apnea

Intervention: Injection Snoreplasty (Procedure)

Phase: N/A

Status: Active, not recruiting

Sponsored by: University of Sao Paulo

Official(s) and/or principal investigator(s):
Fabio TM Lorenzetti, MD, Principal Investigator, Affiliation: University of São Paulo
Michel B Cahali, PhD, Study Director, Affiliation: University of São Paulo


SUMMARY INTRODUCTION: among various treatments for patients with primary snoring, upper airway resistance syndrome (UARS) and obstructive sleep apnea syndrome (OSAS), the injection snoreplasty arose as a promising alternative in some selected cases. OBJECTIVE: to investigate the efficacy and tolerance of injection snoreplasty comparing Ethanol and Ethanolamine Oleate.

Clinical Details

Official title: Injection Snoreplasty: Comparison Between Ethanol and Ethanolamine Oleate. A Randomized, Placebo-Controlled Study in Human Patients

Study design: Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Primary outcome: Snoring


Minimum age: 18 Years. Maximum age: 80 Years. Gender(s): Both.


Inclusion Criteria:

- Snoring

- RDI < 15 /h

Exclusion Criteria:

- BMI > 35

Locations and Contacts

University of São Paulo, São Paulo, SP, Brazil
Additional Information

Starting date: January 2007
Last updated: December 5, 2008

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017